Saturday 17 October 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
222.66
1.67
−0.74%
Follow STE
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
25.65 | 27.78 | 35.26 | 35.40 |
+8 more quarters Free account |
P/S ratio |
3.40 | 3.66 | 4.27 | 4.27 | |
P/FCF ratio |
21.96 | 22.09 | 26.58 | 25.09 | |
P/Operating CF |
55.98 | 64.74 | 83.49 | 84.60 | |
P/B ratio |
2.85 | 3.02 | 3.47 | 3.47 | |
Price to Tangible BV |
14.00 | 15.71 | 20.01 | 23.01 | |
EV/Sales |
3.64 | 3.91 | 4.55 | 4.57 | |
EV/EBITDA |
13.45 | 14.61 | 17.82 | 17.81 | |
EV/Operating CF |
17.05 | 17.30 | 20.92 | 20.02 | |
EV/FCF |
23.46 | 23.61 | 28.29 | 26.85 | |
Quick Ratio |
1.17 | 1.34 | 1.53 | 1.42 | |
Current Ratio |
1.91 | 2.09 | 2.48 | 2.37 | |
Net Debt/EBITDA |
3.44 | 3.39 | 3.73 | 4.07 | |
Debt/Assets |
17.64% | 17.99% | 17.92% | 18.22% | |
Debt/Equity |
0.26 | 0.27 | 0.26 | 0.27 | |
Asset Turnover |
0.57 | 0.57 | 0.57 | 0.55 | |
Operating CF/Net income |
1.83 | 1.52 | 1.55 | 1.50 | |
Capex/Depreciation |
(0.71) | (0.73) | (0.72) | (0.71) | |
Interest Coverage |
18.09 | 21.11 | 18.34 | 17.84 | |
Research and Development Expense of Revenue |
1.92% | 1.81% | 1.97% | 1.93% | |
Selling, General and Administrative Expense of Revenue |
24.77% | 22.16% | 23.55% | 23.95% | |
Intangible Assets out of Total Assets |
0.54 | 0.54 | 0.56 | 0.57 | |
Share Based Compensation of Revenue |
0.86% | 0.81% | 1.05% | 1.45% | |
Graham Net Nets |
(0.05) | (0.05) | (0.05) | (0.05) | |
Graham Number |
116.91 | 114.57 | 108.67 | 105.94 | |
Earnings Yield |
3.90% | 3.60% | 2.84% | 2.82% | |
Free Cash Flow Yield |
4.55% | 4.53% | 3.76% | 3.99% | |
Revenue per Share |
15.29 | 16.17 | 15.24 | 14.84 | |
Operating CF per Share |
3.76 | 3.42 | 3.04 | 2.92 | |
Capex per Share |
(0.90) | (0.92) | (0.90) | (0.88) | |
Free Cash Flow per Share |
2.86 | 2.50 | 2.14 | 2.04 | |
Cash per Share |
4.94 | 4.48 | 4.31 | 3.24 | |
Shareholders Equity per Share |
73.99 | 73.29 | 72.99 | 71.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
73.99 | 73.29 | 72.99 | 71.37 | |
Free Cash Flow |
279.60 | 245.30 | 209.90 | 201.20 | |
Working Capital |
1,162.50 | 1,249.60 | 1,363.90 | 1,217.40 | |
Capital Expenditures |
(87.50) | (90.10) | (88.30) | (86.60) | |
Net Current Asset Value |
(1,069.00) | (1,145.40) | (1,137.30) | (1,281.90) | |
EV/EBIT |
19.24 | 21.06 | 26.46 | 26.77 | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.06 | |
Price to Operating Income |
18.00 | 19.71 | 24.87 | 25.02 | |
| Other line items | |||||
Average Receivables |
980.15 | 1,068.40 | 952.90 | 935.32 | |
Average Payables |
322.50 | 309.80 | 261.70 | 271.99 | |
Average Inventory |
676.65 | 606.55 | 661.53 | 673.72 | |
Average Assets |
10,570.55 | 10,442.00 | 10,299.88 | 10,326.42 | |
Average Common Equity |
7,095.55 | 6,906.55 | 6,798.22 | 6,816.48 |
Columns are period end dates